Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SIM IP (Sauvegarder Investment Management, Inc.) is a Miami-based firm specializing in intellectual property-based financing, investment, and monetization. The company invests across jurisdictions with a focus on the US, Europe, and Asia. It provides capital support for litigation and acquisitions as well as strategic advisory services for global intellectual property monetization. Recent activities include funding Gene Pool Technologies for cannabis/hemp extraction technology licensing and acquiring patent portfolios from tech companies like FusionLayer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SIM IP.